3.1. Baseline Characteristics
Of the 24 patients who completed the NASHFit trial, 20 were included in this analysis (12 exercise, 8 standard of care controls) where serum FGF21 could be measured. The four patients without serum FGF21 were similar in baseline characteristics to the included patients. For patients with measurable serum FGF21, mean patient age was 52 +/−12 years (range 25 to 69 years). Mean body weight was 100.1 +/−18.5 kg, and mean body mass index (BMI) was 32.8 +/− 5.2 kg/m